Committee for Medicinal Products for Human Use (CHMP) has recommended Eli Lilly’s Omvoh (mirikizumab) for approval in the ...

Insights, Trends, Opportunities, and Recent DevelopmentsNew York, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Market Overview The ...

Eli Lilly LLY announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended approving its ...

Crohn’s & Colitis UK are delighted to be awarded a grant of $638,000 from The Leona M. and Harry B. Helmsley Charitable Trust ...

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced ...

Reliance Industries, Dixon Technologies, Ambuja Cements, Biocon, DMart, Waaree Energies, EIH, Aurobindo Pharma, Glenmark, ...

The Nimble acquisition, which follows the $1.4 billion buy of Aliada Therapeutics in October, will help AbbVie rebuild and ...

EMA’s CHMP committee recommends approval of Biocon Biologics’ Yesintek: Our Bureau, Bengaluru Monday, December 16, 2024, 14:30 Hrs [IST] Biocon Biologics (BBL), a fully integr ...

Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel ...

AbbVie has agreed a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will give it control of a ...

Duvakitug is a monoclonal antibody commercialized by Sanofi, with a leading Phase II program in Ulcerative Colitis;Crohn's Disease (Regional Enteritis).

Are you dealing with vitamin B12 deficiency? In this guide, we discuss what this looks like, along with the vitamin B12 ...